“…This has led to the increased use and development of diagnostic methods to streamline the process and improve patient outcomes by decreasing the time needed to identify the cause of an infection, determine whether it is a resistant strain, and adjust patient treatment [ 27 , 28 , 29 ]. This vast range of techniques and their utility in identifying not only infectious diseases but also non-transmissible conditions can be attributed to the progress in technologies that support precision medicine over the last decade, including advances in microfluidic devices [ 30 , 31 , 32 , 33 , 34 ], next-generation sequencing (NGS) and nucleic acid amplification (NAA) methods [ 35 , 36 , 37 , 38 ], mass spectrometry (MS) techniques [ 29 , 38 , 39 , 40 ], laboratory automation [ 41 ], power sources for medical devices [ 42 ], smart materials and nanomaterials for imaging and sensing [ 8 , 43 , 44 , 45 ], biosensing technologies [ 34 , 43 , 46 , 47 , 48 , 49 , 50 ], smart devices for providing mobile power sources and computing power [ 50 , 51 , 52 , 53 ], data analysis techniques such as machine learning (ML) [ 54 , 55 , 56 , 57 ], and improved modeling of disease spread [ 58 ].…”